These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3680564)

  • 21. Pharmacokinetic profile of dextromethorphan hydrobromide in a syrup formulation in children and adolescents.
    Guenin E; Armogida M; Riff D
    Clin Drug Investig; 2014 Sep; 34(9):609-16. PubMed ID: 25027615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous determination of dextromethorphan and three metabolites in plasma and urine using high-performance liquid chromatography with application to their disposition in man.
    Chen ZR; Somogyi AA; Bochner F
    Ther Drug Monit; 1990 Jan; 12(1):97-104. PubMed ID: 2305428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying Levorphanol Ingestion Using Urine Biomarkers in Health Care Patients.
    Watson AR; Roberts A
    Pain Physician; 2018 Mar; 21(2):E167-E171. PubMed ID: 29565959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GC and GC-MS procedures for simultaneous phenotyping with dextromethorphan and mephenytoin.
    Baumann P; Jonzier-Perey M
    Clin Chim Acta; 1988 Feb; 171(2-3):211-22. PubMed ID: 3370821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphism of dextromethorphan oxidation in a French population.
    Larrey D; Amouyal G; Tinel M; Letteron P; Berson A; Labbe G; Pessayre D
    Br J Clin Pharmacol; 1987 Nov; 24(5):676-9. PubMed ID: 3435696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of a new once-daily controlled-release sarpogrelate hydrochloride compared with immediate-release formulation and the effect of food.
    Kim TE; Kim JR; Jung JA; Kim MJ; Lee SY; Ko JW; Jung WT; Choi YW; Lee HJ; Kim SH; Huh W
    J Clin Pharm Ther; 2014 Apr; 39(2):192-5. PubMed ID: 24325365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and bioequivalence of single dose and multiple doses of immediate- and extended-release formulations of dexibuprofen in healthy Chinese subjects.
    Xu MJ; Zou C; H Chu J; Wu T; Liu SJ; Zhang J; Chen M; Liu F; Xiong NN; Ju WZ; S Tan H
    Int J Clin Pharmacol Ther; 2011 Mar; 49(3):237-46. PubMed ID: 21329626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dextromethorphan metabolism in Jordanians: dissociation of dextromethorphan O-demethylation from debrisoquine 4-hydroxylation.
    Irshaid YM; al-Hadidi HF; Latif A; Awwadi F; al-Zoubi M; Rawashdeh NM
    Eur J Drug Metab Pharmacokinet; 1996; 21(4):301-7. PubMed ID: 9074894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dextromethorphan: radioimmunoassay and pharmacokinetics in the dog.
    Dixon R; Carbone JJ; Mohacsi E; Perry C
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):243-55. PubMed ID: 734214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vivo indices of CYP2D6 activity: comparison of dextromethorphan metabolic ratios in 4-h urine and 3-h plasma.
    Chládek J; Zimová G; Beránek M; Martínková J
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):651-7. PubMed ID: 11214771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of dacomitinib (PF-00299804) on CYP2D6 activity in healthy volunteers who are extensive or intermediate metabolizers.
    Bello CL; LaBadie RR; Ni G; Boutros T; McCormick C; Ndongo MN
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):991-7. PubMed ID: 22147075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steady-state pharmacokinetics of controlled release and immediate release formulations of remoxipride in patients with chronic schizophrenia.
    Tench D; Soni SD; Ashwood T; Movin G
    Psychopharmacology (Berl); 1990; 101(1):132-6. PubMed ID: 1971445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of metabolic blockade on the psychoactive effects of dextromethorphan.
    Zawertailo LA; Tyndale RF; Busto U; Sellers EM
    Hum Psychopharmacol; 2010 Jan; 25(1):71-9. PubMed ID: 20041473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.
    Capon DA; Bochner F; Kerry N; Mikus G; Danz C; Somogyi AA
    Clin Pharmacol Ther; 1996 Sep; 60(3):295-307. PubMed ID: 8841152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and polymorphic oxidation of dextromethorphan in a Japanese population.
    Nagai N; Kawakubo T; Kaneko F; Ishii M; Shinohara R; Saito Y; Shimamura H; Ohnishi A; Ogata H
    Biopharm Drug Dispos; 1996 Jul; 17(5):421-33. PubMed ID: 8830977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation.
    Schmid B; Bircher J; Preisig R; Küpfer A
    Clin Pharmacol Ther; 1985 Dec; 38(6):618-24. PubMed ID: 4064464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-point plasma or urine dextromethorphan method for determining CYP3A activity.
    Kuo BP; Hu OY; Hsiong CH; Pao LH; Chen TS; Hung CF
    Biopharm Drug Dispos; 2003 Dec; 24(9):367-73. PubMed ID: 14689465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of terbinafine as a CYP2D6 inhibitor in vivo.
    Abdel-Rahman SM; Gotschall RR; Kauffman RE; Leeder JS; Kearns GL
    Clin Pharmacol Ther; 1999 May; 65(5):465-72. PubMed ID: 10340911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearance.
    Borges S; Li L; Hamman MA; Jones DR; Hall SD; Gorski JC
    Drug Metab Dispos; 2005 Jul; 33(7):1052-5. PubMed ID: 15821042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.